You Can Be Insulin Resistant Before Your Blood Sugar Is High — Here's How

Most people assume blood sugar problems begin when glucose starts rising.

But that isn't necessarily where the story starts.

Insulin resistance can exist while your fasting glucose and A1C are still in the normal range.

The reason is that your body has a powerful backup system:

it can make more insulin.

For a while, that extra insulin may be enough to keep glucose looking completely normal.

Insulin resistance doesn't immediately mean high blood sugar

Insulin resistance means tissues such as your muscle, liver, and fat become less responsive to insulin.

As we explained in Insulin Resistance Isn't Just One Thing, this can affect different organs in different ways.

But imagine your muscle cells now require more insulin than they once did to take up the same amount of glucose.

Your pancreas notices.

Instead of giving up, it compensates by releasing more insulin.

So you can have:

more insulin resistance

↓

more insulin secretion

↓

blood glucose still looks normal

This is called compensatory hyperinsulinemia.

In simple terms:

Your body is using more insulin to achieve the same glucose result.

The pancreas can hide the problem surprisingly well

Consider a simplified example.

Person A

After a meal:

• glucose rises
• pancreas releases a modest amount of insulin
• tissues respond well
• glucose returns toward baseline

Person B

After the same meal:

• glucose rises
• tissues don't respond as well to insulin
• pancreas releases substantially more insulin
• glucose still returns toward baseline

If you looked only at glucose afterward, these people might appear similar.

But metabolically, they got there in very different ways.

Person B had to work much harder.

Researcher Gerald Reaven described this phenomenon decades ago: people vary greatly in how sensitive they are to insulin, and insulin-resistant individuals can maintain normal glucose tolerance by secreting more insulin.

Normal glucose can therefore coexist with substantial insulin resistance.

Think of it like maintaining water pressure

Imagine two houses both have perfectly normal water pressure.

In House A, the plumbing works normally.

In House B, the pipes are partially obstructed.

To maintain the same pressure, the pump has to work much harder.

If you only measure the water coming out of the faucet, both houses look fine.

But the systems are not equally healthy.

That is roughly what can happen with insulin.

Glucose is the output you can easily see.

Insulin is part of the effort required to produce that output.

Eventually compensation may stop being enough

The pancreas can compensate for insulin resistance for years in some people.

But that compensation has limits.

As type 2 diabetes progresses, pancreatic beta cells may become unable to produce enough insulin to overcome the body's degree of insulin resistance.

At that point:

glucose begins to rise.

The progression can look roughly like this:

Stage 1

Insulin sensitivity is relatively good.

• insulin: normal
• glucose: normal

Stage 2

Insulin resistance increases.

The pancreas compensates.

• insulin: higher
• glucose: still relatively normal

Stage 3

Compensation becomes insufficient.

• insulin resistance: high
• insulin response: no longer enough
• glucose: begins rising

Stage 4

More substantial beta-cell dysfunction develops alongside insulin resistance.

• fasting glucose rises further
• post-meal glucose rises
• A1C eventually rises into the diabetes range

Real biology is not divided into four neat stages, and individuals differ considerably.

But the model explains an important point:

High blood sugar can be a relatively late visible sign of a process that began earlier.

This is why A1C doesn't directly measure insulin resistance

An A1C test measures glucose exposure.

It does not measure:

• insulin concentration
• how much insulin your pancreas had to produce
• how sensitive your muscle is to insulin
• how effectively insulin suppresses liver glucose production

So a person with an A1C of 5.4% could theoretically be:

very insulin sensitive

or

more insulin resistant but compensating with higher insulin production.

A1C alone cannot tell you which situation you're in.

That's not a flaw in A1C.

It's simply not the question that test was designed to answer.

Then why don't doctors simply measure fasting insulin?

This seems like the obvious next question.

If high insulin may appear before high glucose, why isn't fasting insulin routinely used to diagnose insulin resistance?

Because measuring insulin resistance accurately is more complicated than it sounds.

The National Institute of Diabetes and Digestive and Kidney Diseases notes that healthcare professionals often do not directly test for insulin resistance, and the most precise tests are primarily used in research.

The American Diabetes Association and laboratory medicine guidelines also state that routine insulin or proinsulin measurement is generally not recommended for most people at risk for diabetes or cardiovascular disease.

There are several reasons.

Insulin assays are not perfectly standardized

A fasting insulin value from one laboratory may not be directly equivalent to a result produced by another assay.

Insulin changes quickly

Levels vary depending on:

• recent food intake
• time of day
• stress
• medications
• insulin clearance
• individual physiology

There is no universally accepted diagnostic cutoff

Unlike A1C or fasting glucose, there isn't one universally agreed number where clinicians can simply say:

"Above this value, you have insulin resistance."

Research tools such as HOMA-IR estimate insulin resistance using fasting glucose and insulin, but they are used more commonly in research and population studies than as a universal clinical diagnostic test.

So fasting insulin can sometimes provide additional context.

It should not be treated as a standalone diagnosis.

There may be clues before glucose rises

Even when A1C is still normal, clinicians may sometimes see patterns associated with insulin resistance.

These can include:

• increasing waist circumference
• higher triglycerides
• lower HDL cholesterol
• elevated blood pressure
• fatty liver disease
• acanthosis nigricans
• polycystic ovary syndrome
• impaired glucose tolerance after a glucose challenge

The 2026 American Diabetes Association Standards specifically identify several of these as conditions associated with insulin resistance and increased diabetes risk.

None proves insulin resistance by itself.

But together, they can tell a broader metabolic story.

Post-meal glucose may also reveal problems earlier than fasting glucose

In our article on A1C vs. Fasting vs. Post-Meal Glucose, we explained why different glucose tests identify different people.

This matters here too.

A person's fasting glucose might still look normal while their body has increasing difficulty handling a glucose challenge.

That is one reason the oral glucose tolerance test can identify abnormal glucose regulation that fasting glucose misses.

And even before glucose becomes dramatically abnormal, researchers can sometimes observe a much larger insulin response required to keep it controlled.

This is also why the response to a metabolic challenge can be more informative than a single fasting measurement.

The "insulin before glucose" idea

A common argument in metabolic health emphasizes fasting insulin over glucose when discussing early dysfunction.

The useful idea underneath that message is valid:

glucose is not always the earliest thing to change.

But it is worth adding an important nuance.

There is no single fasting-insulin threshold that can definitively diagnose insulin resistance across everyone.

So the strongest interpretation isn't:

"Everyone should chase the lowest possible insulin number."

It is:

Metabolic health is bigger than glucose alone.

That distinction matters.

Get the research, without the noise.

Practical, sourced writing on blood sugar and metabolic health. One email a week.

Email addressSubscribe

One email a week. Unsubscribe any time. See our privacy policy.

Does higher insulin cause insulin resistance — or respond to it?

This is an area where simplified explanations can become misleading.

One line of argument emphasizes chronically high insulin as a driver of insulin resistance.

Other researchers emphasize insulin resistance occurring first, followed by compensatory hyperinsulinemia.

The relationship is likely more complex than a simple one-way chain.

Depending on the situation:

• insulin resistance can drive higher insulin secretion
• chronic excess energy intake can affect both
• ectopic fat can impair insulin signaling
• genetics influence beta-cell response
• hyperinsulinemia itself may contribute to metabolic changes

In human type 2 diabetes, the clearest established model is that insulin resistance and beta-cell compensation interact over time.

So rather than arguing over which always comes first, the more useful question is:

How efficiently is the body handling incoming energy?

The real issue is metabolic workload

This leads to an important way of thinking about blood sugar.

Two people can have the exact same glucose reading.

But one person's metabolism may need substantially more insulin to maintain it.

That means the glucose number alone doesn't always reveal the amount of work happening underneath.

And that's where the idea of metabolic flexibility becomes useful.

A metabolically flexible system can adjust effectively when conditions change.

It can:

• handle incoming carbohydrate
• store energy when needed
• use stored energy between meals
• switch fuel sources appropriately
• respond to exercise
• regulate glucose without requiring extreme compensation

The objective isn't simply to force glucose lower at all costs.

It's to reduce the amount of metabolic strain required to keep the system working.

The Health Facts takeaway

One of the biggest misconceptions about insulin resistance is that you'll immediately see it on your blood sugar test.

You may not.

The pancreas can compensate.

For a period of time, it can produce enough additional insulin to keep fasting glucose and A1C looking relatively normal.

That's why the progression toward type 2 diabetes shouldn't be thought of as:

Normal → suddenly diabetic.

It is often a continuum.

Insulin sensitivity can deteriorate.

Insulin production can increase to compensate.

Post-meal handling can become less efficient.

Fat can accumulate in metabolically important places.

And only later may fasting glucose and A1C cross diagnostic thresholds.

That doesn't mean everyone needs dozens of advanced metabolic tests.

It means something simpler:

Don't judge metabolic health from one number alone.

Glucose matters enormously.

But understanding what your body has to do to keep glucose there can sometimes tell you just as much about where the system is heading.